Table II.
Classification of genes whose expression level was potentiated by an IP agonist
| Group | Unigene code | Gene symbol | Gene profiles | Vehicle vs. Il-1β Log2(fold) |
Il-1β vs. Il-1β+Indo Log2(fold) |
Il-1β+Indo vs. Il-1β+Indo+IP agonist Log2(fold) |
|---|---|---|---|---|---|---|
| Inflammation | Mm.35814 | Il11 | Interleukin 11 | 4.1 | −3 | 2.3 |
| Mm.35692 | Il1rl1 | Interleukin 1 receptor–like 1 | 2.3 | −1 | 0.3 | |
| Mm.896 | Il1r1 | Interleukin 1 receptor, type I | 0.7 | −0.7 | 0.9 | |
| Mm.14595 | Csf2rb1 | Colony stimulating factor 2 receptor, β1, low-affinity |
1.5 | −0.6 | 1.3 | |
| Mm.4186 | Pla2g4a | Phospholipase A2, group IVA(cPLA2) (cytosolic, calcium-dependent) |
1.1 | −0.6 | 0.5 | |
| Mm.1401 | Cxcr4 | Chemokine (C-X-C motif) receptor 4 | 0.7 | −1.1 | 1.3 | |
| Mm.157750
|
Cxcl7
|
Chemokine (C-X-C motif) ligand 7
|
1.1
|
−0.8
|
1.2
|
|
| Proliferation | Mm.31540 | Vegfa | VEGF-A | 1.8 | −0.9 | 0.9 |
| Mm.57094 | Fgf2 | FGF-2 | 2.4 | −2.7 | 2 | |
| Mm.57177 | Fgf7 | FGF-7 | 0.9 | −0.6 | 0.5 | |
| Mm.20424 | Fgf18 | FGF-18 | 2.6 | −4 | 2 | |
| Mm.3879 | Hif1a | Hypoxia inducible factor 1, α subunit |
1 | −0.8 | 0.7 | |
| Mm.27969 | Uap1 | UDP-N-acetylglucosamine pyrophosphorylase 1 |
2.7 | −3 | 3.2 | |
| Mm.2580 | Sdc1 | Syndecan 1 | 0.8 | −0.6 | 1.8 | |
| Mm.4575 | Cspg2 | Chondroitin sulfate proteoglycan 2 | 0.8 | −1 | 1.5 | |
| Mm.2542 | Has1 | Hyaluronan synthase1 | 2.2 | −2.7 | 3.3 | |
| Mm.5148
|
Has2
|
Hyaluronan synthase 2
|
1.3
|
−1.6
|
1.8
|
|
| Bone and tissue destruction | Mm.6426 | Tnfsf11 (RANKL) | Tumor necrosis factor (ligand) superfamily, member 11 |
4.2 | −3.1 | 2.9 |
| Mm.1421 | Adamts1 | A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 1 |
2.4 | −1.5 | 0.7 | |
| Mm.39718 | Adamts5 | A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 5 |
1.1 | −0.9 | 0.3 | |
| Mm.15969 | Adam8 | A disintegrin and metalloprotease domain 8 |
0.6 | −0.6 | 1.2 | |
| Mm.44170 | Vdr | Vitamin D receptor | 1.5 | −3.2 | 3.4 |
22 genes are chosen from cluster 4 of Table I and are classified based on their functions. The change in expression level is indicated as a logarithm of the fold-change. Indo, indomethacin.